Novo to test if GLP-1 weight loss drugs can help curb addiction
Novo Nordisk (NVO) plans to run studies on how its GLP-1 class of weight loss/diabetes drug can help people deal with ...
CNET6d
GLP-1 Meds Like Ozempic: Know Potential Benefits, Risk Factors and Overdose Info
Beyond type 2 diabetes and weight loss, GLP-1 agonists can also help lower blood pressure, improve lipid disorders, reduce inflammation and improve heart health. With such advantages, the demand ...
Novo Nordisk to explore how GLP-1 drugs can help patients with addiction
Novo Nordisk will explore how GLP-1 drugs could help patients struggling with addiction, its head of development Martin Holst ...
WebMD29d
GLP-1 Drugs Again Linked to Blindness Risk
“Further studies are needed to test our hypothesis ... eye condition between three months and 16 months after starting a GLP-1 medicine. Last year, a retrospective study published last year ...
A software engineer built an app for tracking her weight-loss shots. In 8 months, it's crossed 100,000 downloads and has $2 million from VCs.
Aja Beckett quit her job after her app for tracking weight-loss shots, Shotsy, took off on Reddit.
Medscape8d
GLP-1 RAs Benefit Kidney Transplant Recipients With T2D
Patients with T2D who undergo kidney transplants are less likely to experience organ failure and mortality if they receive ...
Seeking Alpha7d
Novo to test if GLP-1 weight loss drugs can help curb addiction
Novo’s (NVO) GLP-1 portfolio includes semaglutide ... Late-stage studies are also underway to test its potential in treating early Alzheimer’s disease. "We will further look into this and ...